The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Viridian Therapeutics Inc shares valued at $117,050 were purchased by Beetham Thomas W. on Sep 27 ’24. At $23.41 per share, Beetham Thomas W. acquired 5,000 shares. The insider’s holdings grew to 6,000 shares worth approximately $0.1 million following the completion of this transaction.
Also, Mahoney Stephen F. purchased 21,400 shares, netting a total of over 499,262 in proceeds. Following the buying of shares at $23.33 each, the insider now holds 21,400 shares.
Before that, Fairmount Funds Management LLC had added 1,600,000 shares to its account. In a trade valued at $30,000,000, the Director bought Viridian Therapeutics Inc shares for $18.75 each. Upon closing the transaction, the insider’s holdings increased to 1,600,000 shares, worth approximately $58.79 million.
As published in a research note from Wells Fargo on December 19, 2024, Viridian Therapeutics Inc [VRDN] has been rated down from an Overweight to an Equal weight and the price target has been revised to $27 from $37. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in late November. As of September 11, 2024, Needham has reiterated its “Buy” rating for VRDN. Earlier on June 11, 2024, Wolfe Research initiated its rating. Their recommendation was “an Outperform” for VRDN stock.
Analyzing VRDN Stock Performance
During the last five days, there has been a drop of approximately -10.91%. Over the course of the year, Viridian Therapeutics Inc shares have dropped approximately -11.01%. Shares of the company reached a 52-week high of $21.58 on 01/07/25 and a 52-week low of $16.60 on 01/15/25. A 50-day SMA is recorded $20.34, while a 200-day SMA reached $17.40. Nevertheless, trading volume fell to 1.0 million shares from 1.3 million shares the previous day.
Support And Resistance Levels for Viridian Therapeutics Inc (VRDN)
According to the 24-hour chart, there is a support level at 16.76, which, if violated, would cause prices to drop to 16.46. In the upper region, resistance lies at 17.41. The next price resistance is at 17.77. RSI (Relative Strength Index) is 37.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.85, which suggests the price will decrease in the coming days. Percent R is at 90.76%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
